About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects
Nearly Half of Older Adults Use Online Physician Ratings
Online ratings perceived to be very important nearly as often as word-of-mouth recommendations from family and friends
Excoriation (skin-picking) disorder among adolescents and young adults with acne-induced postinflammatory hyperpigmentation and scars.
A plethora of health-related concerns, including skin disorders, are particularly common during the critical periods of adolescence and young adulthood. Their reactions to skin-related disorders can be different from their …
Children With Worse Atopic Dermatitis More Likely to Have Learning Disabilities
Findings independent of socioeconomic characteristics, onset age, and other related disorders
Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
Microneedling as an adjuvant to topical medications has shown promising but variable results in the treatment of melasma.To conduct a systematic review and meta-analysis on the efficacy of topical therapy …
Onychomycosis in patients with multiple sclerosis: prevalence, clinical description, mycological, and dermoscopic study in a Mexican population.
Multiple sclerosis (MS) is a chronic demyelinating disease related to HLA-DR8. Susceptibility to onychomycosis has been found in Mexican mestizos with HLA-DR8. The frequency of onychomycosis in this neurological disease …
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 trial assessed pembrolizumab versus placebo in patients with resected high-risk stage III melanoma. At 15-month median follow-up, pembrolizumab improved …
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.
The European Organisation for Research and Treatment of Cancer (EORTC) 1325-MG/KEYNOTE-054 trial in patients with resected, high-risk stage III melanoma demonstrated improved recurrence-free survival with adjuvant pembrolizumab compared with placebo …
In-Vitro Diagnostics for the Medical Dermatologist: Part 2: Hypercoagulability Tests.
The skin often provides initial clues of hypercoagulability with features such as livedo reticularis and racemosa, retiform purpura, necrosis and ulcerations. As these cutaneous manifestations are nonspecific, laboratory testing is …
United States Burden of Melanoma and Non-Melanoma Skin Cancer from 1990 to 2019.
Skin cancer is the most common cancer worldwide.To evaluate burden of skin cancer in the US from 1990 to 2019.Age-standardized incidence, prevalence, disability adjusted life years (DALY) and mortality rates …